期刊文献+

高效液相色谱法同时测定人血浆丙泊酚和利多卡因浓度 被引量:6

Determination of propofol and lidocaine concentration in plasma by HPLC
下载PDF
导出
摘要 目的探索一种简易的同时测定人血浆丙泊酚和利多卡因的血药浓度分析方法,为临床研究两种药物之间的相互作用提供科学依据。方法用环己烷提取血浆中的丙泊酚和利多卡因,用高效液相色谱法(high performance liquid chromatography,HPLC)测定丙泊酚和利多卡因的含量。以Shim-packVP-ODS为分离柱,乙腈∶甲醇∶水(10∶60∶30)为流动相,流速为1 mL.min-1,采用外标法,用紫外检测,检测波长:1~6 min用220 nm,6~15 min用270 nm。结果丙泊酚和利多卡因的血药浓度与峰面积比在0.5~32μg.mL-1的范围内呈线性关系(r=0.9994,r=0.9986),检测限分别为0.05μg.mL-1和0.1μg.mL-1,日内和日间偏差小于5%(n=5,n=6)。结论本方法简便,具有较高的精密度和准确度,适用于临床丙泊酚和利多卡因两种药物血药浓度的同时检测。 Objective To develop a method for the determination of propofol and lidocaine concentration in plasma by high performance liquid chromatography(HPLC) and to provide scientific analysis for studies of the pharmacology of propofol and lidocaine in clinical anesthesia.Methods The propofol and lidocaine in plasma was extracted with cyclohexane and was determined by HPLC.The propofol and lidocaine was separated on Shim-pack VP-ODS column with a mobile phase of acetonitril∶ methanol∶ water(10∶ 60∶ 30) at a flow rate of 1 mL·min-1 and detected at 220 nm during 1~6 min and at 270 nm during 6~15 min.Results The linearity between concentrations and peak area ratio was obtained from 0.5 μg·mL-1 to 32 μg·mL-1(r=0.9994,r=0.9986).The detection limits were 0.05 μg·mL-1 for propofol and 0.1 μg·mL-1 for lidocaine.The within-day and between-day variation coefficients were less than 5%(n=5,n=6).Conclusion The reversed-phase HPLC is precise and can be used to measue propofol and lidocaine plasma levels in clinic.
出处 《哈尔滨医科大学学报》 CAS 北大核心 2011年第3期240-242,共3页 Journal of Harbin Medical University
基金 哈尔滨医科大学附属第二医院青年启动基金(QN2008-09)
关键词 丙泊酚 利多卡因 血浆 高效液相色谱法 propofol lidocaine human plasma high performance liquid chromatography
  • 相关文献

参考文献4

二级参考文献7

共引文献50

同被引文献52

  • 1陈静,袁爱武,刘绍乾,谭鹏.毛细管胶束电泳法测定血浆异丙酚方法的研究[J].实用预防医学,2004,11(4):705-707. 被引量:1
  • 2曹兴华,郑宏,王江,王蕊,刘进.气相色谱-质谱法测定丙泊酚血浆和全血浓度的比较[J].临床麻醉学杂志,2004,20(7):405-407. 被引量:10
  • 3马戈,谢文兵,刘晶,李昕洋,金彦伟.氢化物发生原子荧光光谱法直接测定水样中砷(Ⅲ)和砷(Ⅴ)[J].光谱学与光谱分析,2007,27(4):807-809. 被引量:16
  • 4Court MH,Duan SX,Hesse LM,et al.Cytochrome P-450 2B6is responsible for interindividual variability of propofol hydroxylation by human liver microsomes[J].Anesthesiology,2001,94(1):110-119.
  • 5INQRANDE J, BRODSKY JB, LEMMEND HJ. Lean body weight scalar for teanesthetic induction dose of propofol in morbidly obese subject[J]. Anesth Analg, 2011, 113(1): 57-62.
  • 6DURENDIC-BRENESEL M, MIMICA-DUKIC N, PIL1JA V, et al. Gender-related differences in the pharmacokinetics of opiates [J]. Forensic SciInt, 2010, 194(1/2/3): 28-33.
  • 7BIGOS KL, POLLOCK BG, STANKEVICH BA, et al. Sex dif- ference in the pharma-cokineties and pharmaeodynamics of an tidepressants: an updated review[J]. Gend Med, 2009, 6(4): 522- 543.
  • 8Lee SY,Park NH, Jeong EK,etal. Comparison of GC/MS and LC/MS methods for the analysis of propofol and its metabolites in urine[J]. J Chromato B Analyt Technol Biomed Life Sci, 2012, 900 : 1-10.
  • 9Knibbe CA, Koster VS , Deneer VH, etal. Determination of propofol in low-volume samples by high-performance liquid chromatography with fluorescence detection[J]. J Chromatogr BBiomedSciAppl, 1998,706(2) :305-310.
  • 10Teshima D, Nagahama H, Makino K, etal. Microanalysis of propofol in human serum by semi-microcolumn high-perform- ance liquid chromatography with UV detection and solid-phase extraction[J].J Clin Pharm Ther, 2001 ,26(5):381-385.

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部